| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000038353 |
| Receipt No. | R000043707 |
| Scientific Title | Evaluation of titin N-fragment in urine as a marker of muscle catabolism in intensive care |
| Date of disclosure of the study information | 2019/10/21 |
| Last modified on | 2019/10/21 (Ver. 1) |
| Basic information | ||
| Public title | Evaluation of titin N-fragment in urine as a marker of muscle catabolism in intensive care | |
| Acronym | Evaluation of titin N-fragment in urine as a marker of muscle catabolism in intensive care | |
| Scientific Title | Evaluation of titin N-fragment in urine as a marker of muscle catabolism in intensive care | |
| Scientific Title:Acronym | Evaluation of titin N-fragment in urine as a marker of muscle catabolism in intensive care | |
| Region |
|
|
| Condition | ||
| Condition | post intensive care syndrome | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | In order to assess muscle atrophy in intensive care, imaging tests is performed at present.
We evaluate whether urinary titin fragments, a more objective and minimally invasive muscle catabolism marker, correlate with muscle atrophy associated with intensive care. |
| Basic objectives2 | Others |
| Basic objectives -Others | To examine whether changes in urinary titin fragment values in patients undergoing intensive care correlate with changes in thigh muscle mass assessed by CT on days 1 and 10. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | correlation between titin fragment in urine and femoral muscle mass change in 10 days evaluated by CT |
| Key secondary outcomes | correlation between titin fragment in urine and SOFA score, inflammation marker, calorie intake or protein intake |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | ICU admission patients over 20 years old
Patients expected to be hospitalized for 10 days or longer Patients who have obtained consent from the person or a representative |
|||
| Key exclusion criteria | Pregnant women
Under 35 years old or women who can get pregnant Patients without self urine Patients who have difficulty measuring thigh muscle mass after trauma or amputation ECMO patients Other patients who are determined to be inappropriate as subjects by the principal investigator |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hitachi General Hospital | ||||||
| Division name | Department of Emergency and Critical Care Medicine | ||||||
| Zip code | 317-0077 | ||||||
| Address | 2-1-1, Jonancho, Hitachi, Ibaraki, Japan | ||||||
| TEL | 0294-23-1111 | ||||||
| be.rann1988jp@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hitachi General Hospital | ||||||
| Division name | Department of Emergency and Critical Care Medicine, Hitachi General Hospital | ||||||
| Zip code | 317-0077 | ||||||
| Address | 2-1-1, Jonancho, Hitachi, Ibaraki, Japan | ||||||
| TEL | 0294-23-1111 | ||||||
| Homepage URL | |||||||
| be.rann1988jp@gmail.com | |||||||
| Sponsor | |
| Institute | Department of Emergency and Critical Care Medicine, Hitachi General Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hitachi General Hospital Institutional Review Board |
| Address | 2-1-1, Jonancho, Hitachi, Ibaraki, Japan |
| Tel | 0294-23-1111 |
| hitachi.chiken.ha@hitachi.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | none |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043707 |